There was a significantenrichment of miR-21 targets among the genes that were up-regulated in CD4+ Tcells, both when comparing RR-MS patients with HC and when comparing RR-MS withSP-MS but not when SP-MS patients were compared with HC (Table 6). The gene discussed is CD4; the disease is myeloid sarcoma.